Enavate Sciences GP, LLC Q4 2025 Filing
Filed February 17, 2026
Portfolio Value
$506.8B
Holdings
7
Report Date
Q4 2025
Filing Type
13F-HR
All Holdings (7 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ZBIOZENAS BIOPHARMA INC | 3,919,159 | $142.3B | 28.08% | |
| 2 | IMNMIMMUNOME INC | 4,768,583 | $102.4B | 20.21% | |
| 3 | SIONSIONNA THERAPEUTICS INC | 2,478,030 | $101.9B | 20.12% | |
| 4 | UPBUPSTREAM BIO INC | 2,459,703 | $66.8B | 13.18% | |
| 5 | CMPXCOMPASS THERAPEUTICS INC | 7,788,150 | $41.8B | 8.25% | |
| 6 | BBOTBRIDGEBIO ONCOLOGY THERAPEUT | 2,626,946 | $32.9B | 6.49% | |
| 7 | CAMPCAMP4 THERAPEUTICS CORP | 3,035,825 | $18.6B | 3.67% |